China vs Paraguay: Number of new G2D leprosy cases
China
60
in 2024
Paraguay
45
in 2024
China rank
20th
Paraguay rank
23rd
Number of new G2D leprosy cases over time
- China
- Paraguay
How they compare
China currently reports 60 against 45 in Paraguay, a difference of 15.
That makes China's figure about 1.3 times Paraguay's.
Across all 13 years both countries report, China has been ahead every year.
China ranks 20th and Paraguay ranks 23rd of 161 countries.
China has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | China | Paraguay | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 162.38 | 41.25 | 121.12 | China |
| 2020s | 67.2 | 32 | 35.2 | China |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher number of new g2d leprosy cases, China or Paraguay?
- China, at 60 against 45 in Paraguay as of 2024.
- What is the difference in number of new g2d leprosy cases between China and Paraguay?
- 15, with China ahead.
- How many years of comparable data are there for China and Paraguay?
- 13 years are reported by both, from 2012 to 2024.
- How do China and Paraguay rank globally for number of new g2d leprosy cases?
- China ranks 20th and Paraguay ranks 23rd of 161 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Number of new G2D leprosy cases. Statizoid refreshes it automatically from the source and publishes the full history for both places.